BRS2-1-4 - Methionine Cycle Flux

(Balanced Methionine → SAM → SAH → Homocysteine Routing)

1. Mission & Overview + Dietary Levers

Mission

Maintain balanced methionine-cycle flux so methionine availability, SAM-dependent methylation, homocysteine recycling and transsulfuration remain coordinated across changing physiological demand.

Intervention Dominance: Diet-Dominant

Overview

The methionine cycle forms S-adenosylmethionine from methionine, transfers its methyl group, and hydrolyses S-adenosylhomocysteine to adenosine and homocysteine. [2] Homocysteine is then remethylated to methionine or sent into transsulfuration toward cysteine. [12] SAM, SAH and methyl-tetrahydrofolate influence that split. [12] Every tissue can remethylate homocysteine, while transsulfuration is limited to liver, kidney, small intestine and pancreas. [12] Metabolite concentrations describe pool state, not the branch rates. [13]

• Benefits: Maintaining methionine-cycle flux lets cells keep donating methyl groups while directing sulfur toward cysteine. [2] [12] That coordination helps keep methylation and sulfur exit together.
• Implementation Notes: Methionine, dietary protein, vitamin B9 (folate), vitamin B12 (cobalamin), vitamin B6, and vitamin B2 (riboflavin) are the provision routes. [6] [13] Folic acid and vitamin B12 can lower blood homocysteine, and moderate vitamin B6 restriction can raise cystathionine, without a shown change in those branch rates. [6] [13]
• Biological Relevance: SAMe formation, each remethylation reaction, and the transsulfuration enzyme steps are neighbouring mechanisms. [12]

2. Primary Biological Effects

↑ coordinated throughput from methionine through SAM to homocysteine
↔ distribution of homocysteine between remethylation and transsulfuration
→ methylation continues while SAH is hydrolysed onward

3. Intervention Levers

4. Mechanistic Basis

Summary

Methyl-group use and sulfur exit meet at homocysteine. What matters is how that intermediate is divided between return to methionine and transsulfuration, with SAM, SAH and methyl-tetrahydrofolate as effectors of the split.

4.1 Scientific Findings (5)

Summary

A controlled human tracer study found unchanged mean postprandial remethylation, transmethylation and transsulfuration rates during moderate vitamin B6 restriction, despite sharply reduced plasma PLP and increased cystathionine concentration. [13] Pathway reviews provide the regulatory context for these measured branch rates. [2] [12] The combined evidence shows why an altered intermediate concentration cannot be treated as an equivalent change in overall cycle flux; individual responses and the restriction conditions limit generalisation.

5. BRS Pathways and Connections

5.1 BRS Pathways

BRS2-FM1-PM3 — SAMe Synthesis
↓
BRS2-FM1-PM4 — Methionine Cycle Flux
↓
BRS2-FM1-PM1 — Folate/B12-Dependent Homocysteine Remethylation / BRS2-FM1-PM2 — Betaine/BHMT Remethylation
↓
or BRS2-FM2-PM5 — Transsulfuration Pathway

5.2 Cross-BRS Mechanism Relationships

Primary Mechanisms in other Biological Regulatory Systems that directly interact with, constrain or support this mechanism.

• None listed

5.3 Local BRS Mechanism Relationships

Related Primary Mechanisms within the same Biological Regulatory System that collectively support the integrated biological function.

• BRS2-FM1-PM1 — Folate/B12-Dependent Homocysteine Remethylation — Remethylates homocysteine to methionine and thereby carries one recycling exit. The split between that exit and transsulfuration is the upstream allocation.
• BRS2-FM1-PM2 — Betaine/BHMT Remethylation — Remethylates homocysteine to methionine by a betaine-dependent route that runs parallel to folate-dependent recycling and stays separate from transsulfuration.
• BRS2-FM1-PM3 — SAMe Synthesis — Produces SAM from methionine and ATP. That SAM is the methyl donor consumed as throughput moves from methyl transfer to homocysteine and the branch.
• BRS2-FM2-PM5 — Transsulfuration Pathway — Carries homocysteine onward to cystathionine and cysteine after the branch has directed it into transsulfuration, which is the catabolic exit rather than the recycling arm.

7. Phenome Connections

These mappings are translational relationships, not single-mechanism outcome claims. Phenomes are emergent functional patterns supported by multiple interacting PMs across the BRAIN Framework.

Cognitive Clarity — modulatesOpen Page →→

Focus / Attention Stability — modulatesOpen Page →→

Stage 2A/2B dietary-target assessment — 23 October 2026

ENRICHED. Coordination of methionine recycling and SAM-dependent methyl-group handling.

Admit glycine as Direct Type A substrate supply for GNMT methyl-group handling, bounded by primary human-enzyme kinetics and mouse loss-of-function. Add separate human folic-acid tracer evidence without changing existing folate admission or treating concentrations as flux.

New implementation: 1 dietary-input admissions (0 completed Unset candidates), 0 practices, 0 biochemical participants, 1 unscored Findings. Existing accepted inputs, source assessments, mission, KCs, Phenome relationships and scores are retained.

Source-to-claim boundary: Assessment source. Stop after adjudicating the stated material candidate and tracing supported delivery. Keep uncertain specificity, formulation, anatomical or measurement links explicit; no negative evidence is inferred from incomplete retrieval.

8. References

• [1] Aragão et al. (2024) — Riboflavin physiology review
• [2] Chiang et al. (1996) — SAM methyl transfer and SAH hydrolysis
• [3] Fanti et al. (2026) — Methionine balance in a mouse longevity diet
• [4] Parkhitko et al. (2026) — Methionine restriction and ageing
• [5] Kumar et al. (2017) — Transsulfuration toward cysteine
• [6] Collaboration (1998) — Folic acid, B12 and blood homocysteine
• [7] Yu et al. (2020) — Homocysteine among Alzheimer prevention factors
• [8] Luzzi et al. (2022) — Homocysteine and cognitive decline
• [9] Lukovac et al. (2024) — Homocysteine and B12 in boys with ADHD
• [10] Wang et al. (2019) — Diet, B vitamins and childhood ADHD
• [11] Huang et al. (2015) — B12, fish oil and plasma homocysteine
• [12] Finkelstein (1998) — Homocysteine split between remethylation and transsulfuration
• [13] Lamers et al. (2011) — Vitamin B6 restriction and methionine-cycle rates
• [14] FAO (2013) — Dietary protein quality evaluation (DIAAS)
• [15] Froese et al. (2019) — Vitamin B12, folate and methionine remethylation
• [16] Meier et al. (2001) — Human cystathionine beta-synthase structure
• [17] Obeid (2013) — Metabolic Burden of Methyl Donor Deficiency
• [18] Evans et al. (2002) — Human BHMT structure and catalytic zinc
• [19] Salvi and Gadda (2013) — Choline dehydrogenase and betaine formation
• [20] Stam et al. (2005) — Folic Acid and Whole-Body Methyl Flux
• [21] Pakhomova et al. (2004) — Glycine N-methyltransferases: a comparison of the crystal structures and kinetic properties of recombinant human, mouse and rat enzymes.
• [22] Luka et al. (2006) — A glycine N-methyltransferase knockout mouse model for humans with deficiency of this enzyme.

Therapeutic Area evidence

Condition interpretations below reference canonical evidence records; study facts are not rewritten on this mechanism page.

• ADHD
  • brs2-fm1-pm4-ec000133 — Elevated homocysteine, a functional marker of impaired one-carbon metabolism, has been reported in some pediatric ADHD cohorts, although findings remain heterogeneous across studies Open this evidence
  • brs2-fm1-pm4-ec000136 — Unhealthy dietary pattern linked to lower B12, folate, and B6 and to ADHD in case–control path analysis Open this evidence